ESC Congress 2003: Preferred treatment of angina (chest pain)September 01, 2003IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: We have shown that in European and Mediterranean patients with stable angina and proven coronary artery disease the preferred treatment in the majority of patients is mainly determined by the characteristics of the coronary angiogram (x-ray of the coronary arteries). The preferred therapy in these patients was balloon angioplasty, followed by open heart surgery and medical therapy. Between September 2001 and March 2002, we included over 5,500 patients with proven narrowing of coronary arteries on the coronary angiogram in 130 hospitals throughout Europe and the Mediterranean (Euro Heart Survey on Coronary Revascularisation). This survey programme provides systematic information on the management of patients with heart disease. The aim was to assess the relation between the patient, clinical and angiographic, characteristics and the choice of therapy in clinical practice. We studied 2.973 patients with stable angina, defined as a recurring pain or discomfort in the chest when some of the heart muscle does not receive enough blood. Based on an extensive list of patient characteristics we made a model to evaluate the predictors of the treatment. First we compared medical therapy with invasive (open heart surgery and balloon angioplasty) therapy, and second, we compared open heart surgery with balloon angioplasty. Balloon angioplasty involves insertion of a catheter with a tiny balloon at the end into a coronary artery. The balloon is inflated briefly to open the vessel in places where the artery is narrowed. We observed that the number of diseased coronary arteries and the complexity of the narrowing of coronary arteries are the most significant determinants of the therapeutic choice. If a patient has single vessel disease or previously had open heart surgery the therapy is twice to four times as often medical than invasive. Patients with less complicated narrowing are more likely to receive invasive therapy. In the invasive treatment group, the therapeutic choice was significantly more often balloon angioplasty than open heart surgery. The predictors of this treatment were single vessel disease, prior open heart surgery and no accompanying heart valve disease. In patients with a prior heart attack or high blood pressure no treatment was significantly preferred. This research gives insight in the treatment of patients with stable coronary artery disease. Whether the determinants of the choice of therapy influence the eventual health of heart patients needs to be followed up. Dr Marjo Hordijk-Trion Thoraxcentre Rotterdam, Erasmus The Netherlands European Society of Cardiology (ESC) |
|||||||||||||||||||||
| Related Angioplasty Current Events and Angioplasty News Articles Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. The heart attack myth: Study establishes that women do have same the heart attack symptoms as men The gender difference between men and women is a lot smaller than we've been led to believe when it comes to heart attack symptoms. Lifestyle changes remain important in fighting peripheral arterial disease Modifying the risk of peripheral arterial disease (or PAD)-with healthy lifestyle changes-remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. Study questions need for routine intervention in patients with renovascular disease Some invasive procedures that are becoming increasingly common as a first line of treatment for patients diagnosed with narrowed arteries in and around the kidneys may not be necessary. Designing drugs and their antidotes together improves patient care Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Pre-hospital organization: The first links in the chain of survival for heart attack patients Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%. Stent for life initiative Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina). New strategies for reperfusion therapy A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography. More Angioplasty Current Events and Angioplasty News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||